Taysha Gene Therapies, Inc. (TSHA)

TSHA’s near-term technicals skew bearish with weak momentum and limited trend strength. Short- and medium-term moving averages sit above the current price while the 200-day averages lie below, suggesting short-term pressure despite longer-term support. Momentum indicators are tilted negative — the MACD and CCI are signaling selling and the RSI is below neutral — and on-balance volume shows distribution. Volatility is meaningful for the share price, with an ATR near the mid-single-digit percent range, while the pivot sits close to the market. Technical takeaway: Sell-biased near-term technicals amid weak momentum and low trend strength.